Pipeline to Partnerships (P2P)

Category/Phase: ALL / Phase 2

represents column sort

Title	Company Name	Platform / Modality	Target	Investor/Partner Relations
Drug Response Indicator Test	CCC Diagnostics LLC	Imaging		VC, Licensing, Strategic Partner
Fluorosome Technique for Drug Permeability Studies	GLSynthesis Inc.	Small Molecules	All therapeutics	VC, Licensing, Strategic Partner
Gastric Motility Breath Test	Metabolic Solutions, Inc	Biologic		Strategic Partner
GliAtak™	Advantagene, Inc.	Biologic	Patient specific vaccine from non-patient-specific product	Strategic Partner
Oral Clinical Drug for Asthma & COPD	Inverseon, Inc.	Small Molecules	Inflammatory Pathway	VC, Licensing, Manufacturing, Strategic Partner
Oxy-17(R) Tissue Viability Imageing MRI Contrast Media	ROCKLAND TECHNIMED LTD	Imaging	Real time imaging of Cellular Metabolism using unalternate	VC, Strategic Partner
Personal Electrocardiographic Expert System (PELEX)	PinMed, Inc.	Other	Cardiology, Contract Research Organization (CRO), Electronic Medical Records (EMR), Pharmaceutical companies	Strategic Partner
Technology and Device for Asthma Treatment	General Innovations &Goods, Inc.	Other (Device for asthma and infections control)	Reduces airborne allergens and infections agents -The airway inflammation and reactivity associated with asthma will be reduced by lowering the level of exposure to extrinsic factors associated with asthma and by exposing the patient to deactivated airborne allergens.	VC, Licensing